Polymeric drug nanoparticles prepared by an aerosol flow reactor method

被引:25
作者
Eerikäinen, H
Kauppinen, EI [1 ]
Kansikas, J
机构
[1] Aalto Univ, Ctr New Mat, FIN-02044 Espoo, Finland
[2] VTT Proc, Aerosol Technol Grp, FIN-02044 Espoo, Finland
[3] Univ Helsinki, Dept Chem, FIN-00014 Helsinki, Finland
关键词
amorphous; Eudragit; nanoparticles; nanospheres; polymer;
D O I
10.1023/B:PHAM.0000012161.58738.25
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Our purpose was to study the possibility of using a novel method, namely, aerosol flow reactor method, for the preparation of drug-containing nanoparticles with varying amounts of drug and polymer. The physical properties of the prepared nanoparticles were analyzed. Methods. The nanoparticle size distributions were measured using differential mobility analyzer. The structure of the prepared nanoparticles was assessed by x-ray diffraction, differential scanning calorimetry, and electron microscopy. Drug release from the nanoparticles was analyzed. Results. The spherical particles produced showed a unimodal and lognormal size distribution, and the geometric number mean size of the nanoparticles could be varied between 90 and 200 nm. When the amount of drug in the polymeric matrix was small, the nanoparticles had a homogeneous, amorphous structure. Drug crystals were formed when the amount of drug was increased over the solubility limit of the drug into the polymer. The amounts of drug and polymer controlled the drug release from the nanoparticles. Conclusions. The aerosol flow reactor method was found to be able to produce homogeneous amorphous matrix-type nanoparticles that can directly be collected as dry powder.
引用
收藏
页码:136 / 143
页数:8
相关论文
共 30 条
[21]   Process parameters and morphology in amoxicillin micro and submicro particles generation by supercritical antisolvent precipitation [J].
Reverchon, E ;
Della Porta, G ;
Falivene, MG .
JOURNAL OF SUPERCRITICAL FLUIDS, 2000, 17 (03) :239-248
[22]   Production of antibiotic micro- and nano-particles by supercritical antisolvent precipitation [J].
Reverchon, E ;
Della Porta, G .
POWDER TECHNOLOGY, 1999, 106 (1-2) :23-29
[23]   Incorporation of polymeric nanoparticles into solid dosage forms [J].
Schmidt, C ;
Bodmeier, R .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (02) :115-125
[24]  
SHUKLA AJ, 1994, HDB PHARM EXCIPIENTS
[25]  
*TSI INC, 2000, 30753076 TSI INC
[26]   Micronisation and micro encapsulation of pharmaceuticals using a carbon dioxide antisolvent [J].
Tu, LS ;
Dehghani, F ;
Foster, NR .
POWDER TECHNOLOGY, 2002, 126 (02) :134-149
[27]  
*US PHARM CONV, 2001, US PHARM, V25
[28]  
WALTERSSON J, 1985, ACTA PHARM SUEC, V22, P291
[29]  
Wu C, 2001, AAPS PharmSciTech, V2, P24
[30]   Non-traditional plasticization of polymeric films [J].
Wu, CB ;
McGinity, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 177 (01) :15-27